🇺🇸 FDA
Pipeline program

VY-AADC01

PD-1102

Phase 1 small_molecule completed

Quick answer

VY-AADC01 for Idiopathic Parkinson's Disease is a Phase 1 program (small_molecule) at NEUROCRINE BIOSCIENCES INC with 1 ClinicalTrials.gov record(s).

Program details

Company
NEUROCRINE BIOSCIENCES INC
Indication
Idiopathic Parkinson's Disease
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials